(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 8.57% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.71%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.
Stevanato Group Spa's revenue in 2023 is $1,112,434,736.On average, 4 Wall Street analysts forecast STVN's revenue for 2023 to be $343,591,890,453, with the lowest STVN revenue forecast at $338,023,916,175, and the highest STVN revenue forecast at $357,966,957,804. On average, 4 Wall Street analysts forecast STVN's revenue for 2024 to be $386,339,392,340, with the lowest STVN revenue forecast at $372,545,947,780, and the highest STVN revenue forecast at $414,217,092,856.
In 2025, STVN is forecast to generate $418,475,824,775 in revenue, with the lowest revenue forecast at $413,620,101,983 and the highest revenue forecast at $423,375,878,572.